|
Press Releases |
|
 |
|
Tuesday, June 7, 2022 |
|
华领医药在2022ADA科学年会公布多格列艾汀能够明显改善2型糖尿病患者和GCK-MODY患者的胰岛素早相分泌和葡萄糖敏感性 |
华领医药(「公司」,香港联交所股份代号:2552.HK)今天宣布,在第82届美国糖尿病协会(ADA)科学年会上,公司展示了其全球首创新药葡萄糖激酶激活剂(GKA)多格列艾汀(dorzagliatin)的多项临床研究成果。 more info >> |
|
華領醫藥在2022ADA科學年會公佈多格列艾汀能夠明顯改善2型糖尿病患者和GCK-MODY患者的胰島素早相分泌和葡萄糖敏感性 |
華領醫藥(「公司」,香港聯交所股份代號:2552.HK)今天宣佈,在第82屆美國糖尿病協會(ADA)科學年會上,公司展示了其全球首創新藥葡萄糖激酶啟動劑(GKA)多格列艾汀(dorzagliatin)的多項臨床研究成果。 more info >> |
|
Hua Medicine Announces Dorzagliatin can Restore Glucose Sensitivity and Early Phase Insulin Secretion in T2DM and GCK-MODY Patients at ADA 2022 |
Hua Medicine (the "Company", stock code: 2552.HK) today announces that several clinical findings were presented on its global first-in-class drug, glucokinase activator (GKA) dorzagliatin, at the 82nd American Diabetes Association (ADA) Annual Scientific Sessions. more info >> |
|
Friday, May 13, 2022 |
|
祝贺!国际顶级医学期刊《自然-医学》同时发表两篇关于华领医药全球首创糖尿病新药多格列艾汀的III期研究结果的同行评议论文 |
华领医药(“公司”,香港联交所主板股份代号:2552.HK)今日宣布,国际顶级医学刊物《自然-医学》(Nature Medicine)杂志同时在线发表了两篇公司全球首创糖尿病新药葡萄糖激酶激活剂(GKA)多格列艾汀(dorzagliatin)的III期注册临床研究结果的同行评议论文。 more info >> |
|
祝賀!國際頂級醫學期刊《自然-醫學》同時發表兩篇關於華領醫藥全球首創糖尿病新藥多格列艾汀的III期研究結果的同行評議論文 |
華領醫藥(“公司”,香港聯交所主機板股份代號:2552.HK)今日宣佈,國際頂級醫學刊物《自然-醫學》(Nature Medicine)雜誌同時線上發表了兩篇公司全球首創糖尿病新藥葡萄糖激酶啟動劑(GKA)多格列艾汀(dorzagliatin)的III期註冊臨床研究結果的同行評議論文。 more info >> |
|
Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine |
Hua Medicine (the "Company", stock code on the main board of the Hong Kong Stock Exchange: 2552.HK) today announces that, two peer-reviewed papers on the Phase III clinical trial results of dorzagliatin more info >> |
|
Thursday, March 17, 2022 |
|
华领医药公布2021年全年业绩 |
华领医药(「公司」,香港联交所股份代号:2552),今天宣布公司及其附属公司截至2021年12月31日止,经审核的全年业绩(「报告期」)。 more info >> |
|
華領醫藥公佈2021年全年業績 |
華領醫藥(「公司」,香港聯交所股份代號:2552),今天宣佈公司及其附屬公司截至2021年12月31日止,經審核的全年業績(「報告期」)。 more info >> |
|
Hua Medicine Announces 2021 Annual Results |
Hua Medicine (the "Company", Stock Code: 2552.HK) today announces the audited annual results of the Company and its subsidiaries for the year ended December 31, 2021 (the "Reporting Period"). The Reporting Period witnessed significant milestones in the commercialization process of dorzagliatin. more info >> |
|
Sunday, September 26, 2021 |
|
Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin |
Hua Medicine (2552.HK) announced that at the 6th China BioMed Innovation & Investment Conference (CBIIC), Professor Jianhua MA, Director, Department of Endocrinology, Nanjing First Hospital, Standing Member of the Chinese Diabetes Society, as one of the principal researchers presented the results from a clinical study called DREAM, which showed that dorzagliatin, a glucokinase activator and a first-in-class investigational drug of Hua Medicine, may make progress in diabetes remission. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Galaxy Survivor, a New 3D NFT Game, Aims to Foster the Next Blockchain Gaming Generation
Jun 30, 2022 20:00: JST
|
|
|
Galaxy Survivor, a New 3D NFT Game, Aims to Foster the Next Blockchain Gaming Generation
Jun 30, 2022 20:00 HKT/SGT
|
|
|
IBI Group公布二零二二财年全年业绩 面对市场挑战展现强韧抗逆力
Jun 30, 2022 19:23 HKT/SGT
|
|
|
IBI Group公佈二零二二財年全年業績 面對市場挑戰展現強韌抗逆力
Jun 30, 2022 19:22 HKT/SGT
|
|
|
IBI Group Announces FY2022 Annual Results, Steadfast Resilience Albeit Market Challenges
Jun 30, 2022 19:21 HKT/SGT
|
|
|
三菱造船、ヘリコプター搭載型巡視船「あさなぎ」の進水を下関で実施
Jun 30, 2022 17:40: JST
|
|
|
MC and Maruha Nichiro Agree to Establish New Joint Venture in Salmon (land-based)
Jun 30, 2022 18:23 JST
|
|
|
World Blockchain Summit (WBS) Returns to Singapore with an In-Person Event
Jun 30, 2022 17:17: JST
|
|
|
DOCOMO and CyberAgent to Establish New Advertising Company: Prism Partner Inc.
Jun 30, 2022 18:04 JST
|
|
|
三菱重工エンジニアリング、広島市のバイオマス発電所向け、商用初の小型CO2回収装置が稼働開始
Jun 30, 2022 17:00: JST
|
|
|
World Blockchain Summit (WBS) Returns to Singapore with an In-Person Event
Jun 30, 2022 16:17 HKT/SGT
|
|
|
金力永磁荣获稀土永磁行业全球首张SGS PAS 2060碳中和达成宣告核证证书
Jun 30, 2022 13:58 HKT/SGT
|
|
|
金力永磁榮獲稀土永磁行業全球首張SGS PAS 2060碳中和達成宣告核證證書
Jun 30, 2022 13:57 HKT/SGT
|
|
|
JLMAG Awards the First SGS PAS 2060 Carbon Neutrality Declaration Certificate in the Global Rare Earth Permanent Magnet Industry
Jun 30, 2022 13:56 HKT/SGT
|
|
|
MHIENG's First Compact CO2 Capture System Goes into Commercial Operation at Biomass Power Plant in Hiroshima
Jun 30, 2022 14:44 JST
|
|
|
|
More News >> |
|
|
|
|
|